Skip to content
healthcare.dev

Cardizem LA

NDC 0187-2049, Diltiazem Hydrochloride, tablet, extended release, from Bausch Health US LLC.

Product NDC
0187-2049
Status
Listed
Labeler
Bausch Health US LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021392
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0187-2049 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DILTIAZEM HYDROCHLORIDE360 mg/1

Pharmacologic classes

Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A4 Inhibitors [MoA]

Package NDCNDC-11Package
0187-2049-300018720493030 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-2049-30)
0187-2049-900018720499090 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-2049-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3e180dc7-c871-4efc-8755-cae882976c8d

Use it

Look up 0187-2049 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0187-2049 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0187-2049. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.